Standard
Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients : a nation-wide cohort study. / Beaman, E.; Bonde, A. N.; Larsen, S. M. Ulv; Ozenne, B.; Lohela, T. J.; Gislason, G. H.; Knudsen, G. M.; Holst, S. C.
In:
European Neuropsychopharmacology, Vol. 40, 2020, p. S219-S220.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Beaman, E, Bonde, AN, Larsen, SMU
, Ozenne, B, Lohela, TJ
, Gislason, GH, Knudsen, GM & Holst, SC 2020, '
Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients: a nation-wide cohort study',
European Neuropsychopharmacology, vol. 40, pp. S219-S220.
https://doi.org/10.1016/j.euroneuro.2020.09.286APA
Beaman, E., Bonde, A. N., Larsen, S. M. U.
, Ozenne, B., Lohela, T. J.
, Gislason, G. H., Knudsen, G. M., & Holst, S. C. (2020).
Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients: a nation-wide cohort study.
European Neuropsychopharmacology,
40, S219-S220.
https://doi.org/10.1016/j.euroneuro.2020.09.286Vancouver
Beaman E, Bonde AN, Larsen SMU
, Ozenne B, Lohela TJ
, Gislason GH et al.
Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients: a nation-wide cohort study.
European Neuropsychopharmacology. 2020;40:S219-S220.
https://doi.org/10.1016/j.euroneuro.2020.09.286Author
Beaman, E. ; Bonde, A. N. ; Larsen, S. M. Ulv ; Ozenne, B. ; Lohela, T. J. ; Gislason, G. H. ; Knudsen, G. M. ; Holst, S. C. / Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients : a nation-wide cohort study. In: European Neuropsychopharmacology. 2020 ; Vol. 40. pp. S219-S220.
Bibtex
@article{8b4fba91c2404b5da0161c2b784c3ac7,
title = "Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients: a nation-wide cohort study",
author = "E. Beaman and Bonde, {A. N.} and Larsen, {S. M. Ulv} and B. Ozenne and Lohela, {T. J.} and Gislason, {G. H.} and Knudsen, {G. M.} and Holst, {S. C.}",
year = "2020",
doi = "10.1016/j.euroneuro.2020.09.286",
language = "English",
volume = "40",
pages = "S219--S220",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
note = "33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP) ; Conference date: 12-09-2020 Through 15-09-2020",
}
RIS
TY - ABST
T1 - Effect of beta-adrenergic antagonists on the risk of alzheimer's disease amongst hypertensive patients
T2 - 33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP)
AU - Beaman, E.
AU - Bonde, A. N.
AU - Larsen, S. M. Ulv
AU - Ozenne, B.
AU - Lohela, T. J.
AU - Gislason, G. H.
AU - Knudsen, G. M.
AU - Holst, S. C.
PY - 2020
Y1 - 2020
U2 - 10.1016/j.euroneuro.2020.09.286
DO - 10.1016/j.euroneuro.2020.09.286
M3 - Conference abstract in journal
VL - 40
SP - S219-S220
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
SN - 0924-977X
Y2 - 12 September 2020 through 15 September 2020
ER -
